PAVmed Inc
PAVMZ0.001USD
-0.001-54.17%
Close 04/25, 16:00（ET）Quotes delayed by 15 min
12.32KMarket Cap
0.00P/E TTM
More Details of PAVmed Inc Company
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.
Company Info
Company codePAVMZ
Company namePAVmed Inc
IPO dateJul 27, 2016
Founded at2014
CEODr. Lishan Aklog, M.D.
Number of employees39
Security typeCompany Warrant
Fiscal year-endJul 27
Address360 Madison Avenue
CityNEW YORK
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code10017
Phone12129494319
Websitehttps://pavmed.com/
Company codePAVMZ
IPO dateJul 27, 2016
Founded at2014
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Lishan Aklog, M.D.
Dr. Lishan Aklog, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Michael A. Gordon
Mr. Michael A. Gordon
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Timothy (Tim) Baxter
Mr. Timothy (Tim) Baxter
Independent Director
Independent Director
--
--
Mr. Matt Riley
Mr. Matt Riley
Director of Investor Relations
Director of Investor Relations
--
--
Mr. Sundeep Agrawal, M.D.
Mr. Sundeep Agrawal, M.D.
Director
Director
--
--
Mr. Shaun M. O'Neil
Mr. Shaun M. O'Neil
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Mr. Michael J. Glennon
Mr. Michael J. Glennon
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Debra J. White
Ms. Debra J. White
Independent Director
Independent Director
--
--
Dr. Brian J. Deguzman, M.D.
Dr. Brian J. Deguzman, M.D.
Chief Technology Officer, Chief Compliance Officer
Chief Technology Officer, Chief Compliance Officer
--
--
Ronald M Sparks ,Jr
Ronald M Sparks ,Jr
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Lishan Aklog, M.D.
Dr. Lishan Aklog, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Michael A. Gordon
Mr. Michael A. Gordon
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Timothy (Tim) Baxter
Mr. Timothy (Tim) Baxter
Independent Director
Independent Director
--
--
Mr. Matt Riley
Mr. Matt Riley
Director of Investor Relations
Director of Investor Relations
--
--
Mr. Sundeep Agrawal, M.D.
Mr. Sundeep Agrawal, M.D.
Director
Director
--
--
Mr. Shaun M. O'Neil
Mr. Shaun M. O'Neil
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholder
Update time: Sun, Feb 23
Update time: Sun, Feb 23
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Other
100.00%
Shareholder Statistics
Shareholder
Proportion
Other
100.00%
Type
Shareholder
Proportion
Other
100.00%
Institutional Shareholding
Update time: Tue, Mar 4
Update time: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
8
188.90K
0.00%
-124.43K
2024Q4
9
188.90K
0.00%
-125.43K
2024Q3
10
51.25K
0.00%
-314.00K
2024Q2
11
42.91K
0.00%
-324.41K
2024Q1
11
780.00
0.00%
-386.44K
2023Q4
11
700.00
0.00%
-386.52K
2023Q3
11
22.97K
0.00%
-343.31K
2023Q2
11
242.32K
0.00%
-333.08K
2023Q1
10
492.21K
0.00%
-40.52K
2022Q4
9
450.53K
0.00%
+183.63K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Susquehanna International Group, LLP
138.19K
0%
+138.19K
--
Dec 31, 2024
Citadel Advisors LLC
42.89K
0%
+200.00
+0.47%
Dec 31, 2024
UBS Financial Services, Inc.
7.71K
0%
-749.00
-8.86%
Dec 31, 2024
BofA Global Research (US)
100.00
0%
--
--
Dec 31, 2024
Levin Capital Strategies, L.P.
--
0%
-45.77K
-100.00%
Sep 30, 2023
Raymond James & Associates, Inc.
--
0%
-174.54K
-100.00%
Sep 30, 2023
PNC Investments LLC
--
0%
-1.00K
-100.00%
Dec 31, 2023
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data